Results showed that inhibition of PBX3 suppressed the expression of N-cadherin, ZEB1, Slug and CD44 (Fig. 7d), indicating that downregulation of PBX3 inhibits GBM mesenchymal transition in vivo. Here, SNAI2 is linked to glioblastoma.